H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12% of adults in Ontario have diagnosed diabetes — about even with the U.S. 12% figure. Census population 175,265. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Ontario clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Ontario storefront.
Growth Factor Therapy for Tissue Repair in Ontario, CA for clinics & physicians. Growth factor therapy pro… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into a California chart is a denial pattern. You are JE. CDC PLACES (2023, crude) estimates 12% of adults in Ontario have diagnosed diabetes — about even with the U.S. 12% figure. Use California Department of Public Health for community education; use the IFU for the product in the fridge. growth factor therapy is the SKU conversation, not a patient appointment book.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)California shares JE with HI, NV. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 12% of adults in Ontario have diagnosed diabetes — about even with the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 12% of adults in Ontario have diagnosed diabetes — about even with the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the growth factor therapy account.
CDC PLACES (2023, crude prevalence) estimates 12% of adults — about even with the U.S. 12% figure. Obesity is 33.6%; arthritis is 19.6%. That is place-level BRFSS modeling, not a clinic census and not a Ontario trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including California.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JE reviewers and surveyors expect — not a brochure.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed California clinician.
Bring specialty, monthly joint / regenerative volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12% diabetes and 19.6% arthritis for Ontario — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Ontario, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Ontario is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Ontario — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Ontario. Useful for joint-program math; still needs a diagnosis and privileging.
No Ontario storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.